Pacer Advisors
ARNA

Pacer Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Pacer Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,010
Closed -$70K – 1603
2021
Q1 		$70K Sell
1,010
-896
-47% -$68.9K ﹤0.01% 1375
2020
Q4 		$146K Buy
1,906
+192
+11% +$14.4K ﹤0.01% 1288
2020
Q3 		$128K Buy
+1,714
New +$114K ﹤0.01% 1225
2018
Q4 		– Sell
-5,473
Closed -$252K – 1123
2018
Q3 		$252K Buy
+5,473
New +$222K 0.01% 983
2018
Q1 		– Sell
-1,550
Closed -$53K – 1154
2017
Q4 		$53K Buy
+1,550
New +$44.2K ﹤0.01% 1007

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors's ARNA Position: Q2 2021 in Review

Pacer Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 1,010 shares — an estimated $70K sold.

Pacer Advisors first reported a position in ARNA in Q4 2017 and held it in 5 quarters. The position peaked at $252K in Q3 2018. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

  • Pacer Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 1,010 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $70K.
  • Pacer Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 5 quarters.
  • Pacer Advisors's Arena Pharmaceuticals Inc position peaked at $252K in Q3 2018.
  • 237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.